Clinical Trial Update: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating concomitant ixekizumab with tirzepatide in adults with plaque psoriasis and obesity is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Plaque Psoriasis

Drugs mentioned

• MOUNJARO (tirzepatide)
• TALTZ (IXEKIZUMAB)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Psoriasis, Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING